Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ecstasy and neurodegeneration.

× No keyword cloud information.

11 in total

1. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.

Authors: S Przedborski; V Kostic; V Jackson-Lewis; A B Naini; S Simonetti; S Fahn; E Carlson; C J Epstein; J L Cadet
Journal: J Neurosci Date: 1992-05 Impact factor: 6.167

2. Reorganization of ascending 5-HT axon projections in animals previously exposed to the recreational drug (+/-)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

Authors: C Fischer; G Hatzidimitriou; J Wlos; J Katz; G Ricaurte
Journal: J Neurosci Date: 1995-08 Impact factor: 6.167

3. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

Authors: J W Langston; P Ballard; J W Tetrud; I Irwin
Journal: Science Date: 1983-02-25 Impact factor: 47.728

4. Diversity of psychopathology associated with use of 3,4-methylenedioxymethamphetamine ('Ecstasy')

Authors: P K McGuire; H Cope; T A Fahy
Journal: Br J Psychiatry Date: 1994-09 Impact factor: 9.319

5. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions.

Authors: F J Vingerhoets; B J Snow; J W Tetrud; J W Langston; M Schulzer; D B Calne
Journal: Ann Neurol Date: 1994-11 Impact factor: 10.422

6. The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.

Authors: M I Colado; A R Green
Journal: Eur J Pharmacol Date: 1995-07-14 Impact factor: 4.432

7. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.

Authors: M I Colado; J L Williams; A R Green
Journal: Br J Pharmacol Date: 1995-08 Impact factor: 8.739

8. (+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates.

Authors: G A Ricaurte; L S Forno; M A Wilson; L E DeLanney; I Irwin; M E Molliver; J W Langston
Journal: JAMA Date: 1988-07-01 Impact factor: 56.272

9. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

Authors: U D McCann; A Ridenour; Y Shaham; G A Ricaurte
Journal: Neuropsychopharmacology Date: 1994-04 Impact factor: 7.853

Review 10. Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

Authors: A R Green; A J Cross; G M Goodwin
Journal: Psychopharmacology (Berl) Date: 1995-06 Impact factor: 4.530

9 in total

1. Ecstasy and neurodegeneration. No evidence of neurotoxicity exists.

Authors: N Saunders
Journal: BMJ Date: 1996-08-17

2. Ecstasy and neurodegeneration. Advice is that "less is more".

Authors: J Merrill
Journal: BMJ Date: 1996-08-17

3. Ecstasy and neurodegeneration. ...such as ketamine.

Authors: D Shewan; P Dalgarno
Journal: BMJ Date: 1996-08-17

4. Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness.

Authors: J M Stell; J M Ryan
Journal: BMJ Date: 1996-08-17

5. Ecstasy and neurodegeneration. Tablets often contain substances in addition to, or instead of, ecstasy...

Authors: A R Winstock; L A King
Journal: BMJ Date: 1996-08-17

Review 6. Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans.

Authors: A R Green; M V King; S E Shortall; K C F Fone
Journal: Br J Pharmacol Date: 2012-07 Impact factor: 8.739

7. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

Authors: R de la Torre; M Farré; J Ortuño; M Mas; R Brenneisen; P N Roset; J Segura; J Camí
Journal: Br J Clin Pharmacol Date: 2000-02 Impact factor: 4.335

Review 8. Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") and its congeners.

Authors: G Huether; D Zhou; E Rüther
Journal: J Neural Transm (Vienna) Date: 1997 Impact factor: 3.575

9. Garcinia kola Attenuates MDMA-Induced Neuroinflammation in the CA1 Region of the Hippocampus in the Rat Model.

Authors: Sunday Yinka Olatunji; Iheanyichukwu Okoro; Joshua Oladele Owolabi; John Afees Olanrewaju; Stephen Taiye Adelodun; Sunday Oluseyi Fabiyi
Journal: Ann Neurosci Date: 2021-01-22

9 in total